PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Alchemab Therapeutics Ltd, London, United Kingdom.\', \'Wellcome Centre for Human Genetics, Oxford, United Kingdom.\', \'Oxford Protein Informatics Group, Department of Statistics, University of Oxford, Oxford, United Kingdom.\', \'Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.\', \'Illumina, Inc., Illumina Centre, Cambridge, United Kingdom.\', \'Translational Research Program, Vall d\'Hebron Institute of Oncology, Barcelona, Spain.\', \'Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2020.605170
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 33384691
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33384691>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33384691>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all